secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sotera Health Co (SHC)
CIK:        0001822479
Form:       8-K
Filed at:   2023-11-13T23:59:59+00:00
Accession:  0001822479-23-000065
Event type: leadership
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sotera Health appoints Karen A. Flynn as new director, board expanded to 11
---------------------------------------------------------------------------

- Board increased from 10 to 11 members; Karen A. Flynn appointed effective Nov 13, 2023.
- Flynn most recently served as Interim President of BioModalities at Catalent Pharma Solutions.
- She is deemed independent under Nasdaq rules and will serve as Class II director until 2025 annual meeting.
- She will receive standard non-employee director compensation (annual cash retainer + RSU grant).
- No arrangements or transactions requiring disclosure; enters customary indemnification agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822479/000182247923000065/0001822479-23-000065-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822479/000182247923000065/shc-20231113.htm
  HTML page:      https://secwatch.observer/filing/0001822479-23-000065

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer